Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 5,000 shares at $3.81 ($19K) on 2015-01-21, disclosed to the SEC on 2015-01-23.
Open-market purchase of $19k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |
| MEIP | BUY | 2014-07-02 | $13K | — | Filing → |